4.8 Article

Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer

Journal

SCIENCE
Volume 346, Issue 6205, Pages 85-89

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1250255

Keywords

-

Funding

  1. Swiss Science foundation [SSMBS PASMP3_145764]
  2. SystemX.ch grant (PhophoNet PPM), the Swiss initiative in systems biology
  3. Novartis Foundation Medicine
  4. Boehringer Ingelheim
  5. Millennium/Takeda

Ask authors/readers for more resources

Cancer genome characterization has revealed driver mutations in genes that govern ubiquitylation; however, the mechanisms by which these alterations promote tumorigenesis remain incompletely characterized. Here, we analyzed changes in the ubiquitin landscape induced by prostate cancer-associated mutations of SPOP, an E3 ubiquitin ligase substrate-binding protein. SPOP mutants impaired ubiquitylation of a subset of proteins in a dominant-negative fashion. Of these, DEK and TRIM24 emerged as effector substrates consistently up-regulated by SPOP mutants. We highlight DEK as a SPOP substrate that exhibited decreases in ubiquitylation and proteasomal degradation resulting from heteromeric complexes of wild-type and mutant SPOP protein. DEK stabilization promoted prostate epithelial cell invasion, which implicated DEK as an oncogenic effector. More generally, these results provide a framework to decipher tumorigenic mechanisms linked to dysregulated ubiquitylation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available